119 related articles for article (PubMed ID: 3962678)
21. Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.
von Rosen A; Rutqvist LE; Carstensen J; Fallenius A; Skoog L; Auer G
Breast Cancer Res Treat; 1989 Jan; 13(1):23-32. PubMed ID: 2706326
[TBL] [Abstract][Full Text] [Related]
22. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
23. Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli.
Rosen PP; Saigo PE; Braun DW; Beattie EJ; Kinne DW
Am J Surg Pathol; 1982 Oct; 6(7):639-41. PubMed ID: 7180963
[TBL] [Abstract][Full Text] [Related]
24. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
25. A clinical study to assess the pathological involvement of occult supraclavicular lymphnode metastasis in case of locally advanced operable breast carcinoma.
Virani SJ; Patni S; Shah R
Indian J Cancer; 2015; 52(3):282-5. PubMed ID: 26905111
[TBL] [Abstract][Full Text] [Related]
26. High levels of DNA index heterogeneity in advanced breast carcinomas. Evidence for DNA ploidy differences between lymphatic and hematogenous metastases.
Bonsing BA; Beerman H; Kuipers-Dijkshoorn N; Fleuren GJ; Cornelisse CJ
Cancer; 1993 Jan; 71(2):382-91. PubMed ID: 8422632
[TBL] [Abstract][Full Text] [Related]
27. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
[TBL] [Abstract][Full Text] [Related]
28. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.
Hedley DW; Rugg CA; Ng AB; Taylor IW
Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193
[TBL] [Abstract][Full Text] [Related]
29. Relationship between DNA ploidy and survival in patients with primary breast cancer.
Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
[TBL] [Abstract][Full Text] [Related]
30. Pathologic correlates of prognosis in lymph node-positive breast carcinomas.
Clayton F; Hopkins CL
Cancer; 1993 Mar; 71(5):1780-90. PubMed ID: 8383579
[TBL] [Abstract][Full Text] [Related]
31. DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma.
Klintenberg C; Wallgren A; Bjelkenkrantz K; Carstenssen J; Humla S; Nordenskjöld B; Skoog L
Acta Radiol Oncol; 1985; 24(3):253-8. PubMed ID: 2994376
[TBL] [Abstract][Full Text] [Related]
32. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
Sauer T; Furu I; Beraki K; Jebsen PW; Ormerod E; Naess O
Cancer; 1998 Apr; 84(2):109-14. PubMed ID: 9570214
[TBL] [Abstract][Full Text] [Related]
33. DNA content in primary tumours and lymph node metastases in colorectal adenocarcinoma.
Koha M; Brismar B; Wikström B
APMIS; 1992 Jul; 100(7):640-4. PubMed ID: 1642852
[TBL] [Abstract][Full Text] [Related]
34. Prediction of supraclavicular lymph node metastasis in breast carcinoma.
Chen SC; Chen MF; Hwang TL; Chao TC; Lo YF; Hsueh S; Chang JT; Leung WM
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):614-9. PubMed ID: 11849781
[TBL] [Abstract][Full Text] [Related]
35. [Cell nucleus analyses on the heterogenicity, proliferation and metastasis of malignant tumors].
Kunze KD; Haroske G; Dimmer V; Meyer W; Theissig F
Acta Histochem Suppl; 1990; 39():147-54. PubMed ID: 1964231
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma.
Erhardt K; Auer G; Fallenius A; Folin A; Forsslund G; Silfverswärd C; Zetterberg A
Am J Clin Oncol; 1986 Apr; 9(2):117-25. PubMed ID: 3012992
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: comparison with nonmetastatic Barrett's adenocarcinoma.
Walch AK; Zitzelsberger HF; Bink K; Hutzler P; Bruch J; Braselmann H; Aubele MM; Mueller J; Stein H; Siewert JR; Höfler H; Werner M
Mod Pathol; 2000 Jul; 13(7):814-24. PubMed ID: 10912943
[TBL] [Abstract][Full Text] [Related]
38. Axillary lymph node metastases from unknown primary: A French multicentre study.
Ouldamer L; Cayrol M; Vital M; Fièvre C; Druelles M; Arbion F; Body G; Lévêque J; Fritel X
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():103-107. PubMed ID: 29518639
[TBL] [Abstract][Full Text] [Related]
39. Infiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary?
Saiz E; Toonkel R; Poppiti RJ; Robinson MJ
Cancer; 1999 May; 85(10):2206-11. PubMed ID: 10326699
[TBL] [Abstract][Full Text] [Related]
40. Staging of breast cancer: a new rationale for internal mammary node biopsy.
Morrow M; Foster RS
Arch Surg; 1981 Jun; 116(6):748-51. PubMed ID: 7016069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
